De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
PEPTONIC medical Inkomsten in het verleden
Verleden criteriumcontroles 0/6
PEPTONIC medical's earnings have been declining at an average annual rate of -21.8%, while the Pharmaceuticals industry saw earnings growing at 10.4% annually. Revenues have been growing at an average rate of 46.6% per year.
Belangrijke informatie
-21.8%
Groei van de winst
1.1%
Groei van de winst per aandeel
| Pharmaceuticals Groei van de industrie | 30.5% |
| Inkomstengroei | 46.6% |
| Rendement op eigen vermogen | -40.5% |
| Nettomarge | -76.5% |
| Volgende winstupdate | 07 May 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe PEPTONIC medical geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 23 | 41 | -31 | 48 | 0 |
| 30 Jun 23 | 43 | -32 | 49 | 0 |
| 31 Mar 23 | 44 | -34 | 51 | 0 |
| 31 Dec 22 | 44 | -37 | 56 | 0 |
| 30 Sep 22 | 39 | -74 | 69 | 0 |
| 30 Jun 22 | 34 | -75 | 69 | 0 |
| 31 Mar 22 | 29 | -78 | 69 | 0 |
| 31 Dec 21 | 32 | -74 | 65 | 0 |
| 30 Sep 21 | 33 | -40 | 55 | 0 |
| 30 Jun 21 | 35 | -37 | 54 | 0 |
| 31 Mar 21 | 31 | -32 | 48 | 0 |
| 31 Dec 20 | 21 | -31 | 42 | 0 |
| 30 Sep 20 | 14 | -30 | 36 | 0 |
| 30 Jun 20 | 7 | -27 | 28 | 0 |
| 31 Mar 20 | 5 | -26 | 25 | 0 |
| 31 Dec 19 | 4 | -25 | 24 | 0 |
| 30 Sep 19 | 4 | -20 | 19 | 0 |
| 30 Jun 19 | 3 | -19 | 18 | 0 |
| 31 Mar 19 | 2 | -17 | 15 | 0 |
| 31 Dec 18 | 0 | -15 | 14 | 0 |
| 30 Sep 18 | 0 | -15 | 13 | 0 |
| 30 Jun 18 | 0 | -14 | 12 | 0 |
| 31 Mar 18 | 0 | -13 | 11 | 0 |
| 31 Dec 17 | 0 | -13 | 11 | 0 |
| 30 Sep 17 | 0 | -11 | 10 | 0 |
| 30 Jun 17 | 0 | -10 | 9 | 0 |
| 31 Mar 17 | 0 | -10 | 9 | 0 |
| 31 Dec 16 | 0 | -11 | 10 | 0 |
| 30 Sep 16 | 0 | -13 | 13 | 0 |
| 30 Jun 16 | 0 | -14 | 14 | 0 |
| 31 Mar 16 | 0 | -15 | 15 | 0 |
| 31 Dec 15 | 0 | -14 | 14 | 0 |
| 30 Sep 15 | 0 | -13 | 6 | 0 |
| 30 Jun 15 | 0 | -13 | 6 | 0 |
| 31 Mar 15 | 0 | -12 | 4 | 0 |
| 31 Dec 14 | 0 | -10 | 3 | 0 |
| 30 Sep 14 | 0 | -8 | 4 | 0 |
| 30 Jun 14 | 0 | -7 | 3 | 0 |
| 31 Mar 14 | 0 | -5 | 2 | 0 |
Kwaliteitswinsten: PMED is currently unprofitable.
Groeiende winstmarge: PMED is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: PMED is unprofitable, and losses have increased over the past 5 years at a rate of 21.8% per year.
Versnelling van de groei: Unable to compare PMED's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: PMED is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (2.7%).
Rendement op eigen vermogen
Hoge ROE: PMED has a negative Return on Equity (-40.53%), as it is currently unprofitable.